Medicamen Biotech Ltd. NSE: MEDICAMEQ | BSE: 531146

Mid-range Performer

Download real time

341.05 2.45 (0.72%)

New 52W Low in past week

15,558

NSE+BSE Volume

NSE 17 Sep, 2025 3:31 PM (IST)

Dividend

Medicamen Biotech Ltd. has an upcoming dividend of ₹1.00 per share due on 19 Sep 2025 See details

Medicamen Biotech Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Medicamen Biotech Ltd. on BSE

Load latest

Medicamen Biotech Ltd.

03 Jun 2025

341.05

0.72%

Company Update

Medicamen Biotech Ltd-$ - 531146 - Announcement Under Regulation 30 (LODR)- Approval Of Abbreviated New Drug …

BSE India

Announcement under Regulation 30 (LODR) - Approval of Abbreviated New Drug Application (ANDA)

Medicamen Biotech Ltd.

02 Jun 2025

341.05

0.72%

Company Update

Medicamen Biotech Ltd-$ - 531146 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper publication of Audited Financial Results for the quarter and year ended on March 31, 2025

Medicamen Biotech Ltd.

30 May 2025

341.05

0.72%

Company Update

Medicamen Biotech Ltd-$ - 531146 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Compliance - Reg 24 (A)- Annual Secretarial Compliance Report - March 31, 2025

Medicamen Biotech Ltd.

30 May 2025

341.05

0.72%

Result

Medicamen Biotech Ltd-$ - 531146 - Financial Results Year Ended On 31.03.2025

BSE India

Financial Results year ended on 31.03.2025

Medicamen Biotech Ltd.

30 May 2025

341.05

0.72%

Annual Report

Annual report for Medicamen Biotech Ltd. for FY-2025

None

Medicamen Biotech Ltd.

22 May 2025

341.05

0.72%

Board Meeting

Medicamen Biotech Ltd-$ - 531146 - Board Meeting Intimation for Board Meeting Intimation As Per Regulation …

BSE India

Medicamen Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve Medicamen Biotech Limited has informed that meeting of the Board of Directors of the Company is scheduled on 30.05.2025, inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the financial year ended on 31.03.2025 and to consider recommending payment of dividend to the shareholders.

Medicamen Biotech Ltd.

28 Apr 2025

341.05

0.72%

SAST

Medicamen Biotech Ltd-$ - 531146 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shivalik Rasayan Ltd & PACs

Medicamen Biotech Ltd.

25 Apr 2025

341.05

0.72%

Company Update

Medicamen Biotech Ltd-$ - 531146 - Corrigendun To The Outcome Of The Board Meeting - April …

BSE India

Corrigendum to the Outcome of the meeting of the Board Meeting of Board of Directors of Medicamen Biotech Limited ("the Company") in accordance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) Regulations, 2015

Medicamen Biotech Ltd.

25 Apr 2025

341.05

0.72%

Company Update

Medicamen Biotech Ltd-$ - 531146 - Board Meeting Outcome for Revised Outcome Of Board Meeting 24.04.2025

BSE India

Revised outcome of Board Meeting - 24.04.2025

Medicamen Biotech Ltd.

25 Apr 2025

341.05

0.72%

Company Update

Medicamen Biotech Ltd-$ - 531146 - Board Meeting Outcome for Outcome Of Board Meeting - April …

BSE India

Outcome of Board Meeting - April 24, 2025

Is Medicamen Biotech Ltd. worth buying?

39 Votes:

Buy 76.92%

Sell 17.95%

Hold 5.13%